tiprankstipranks

Evolent Health price target lowered to $12 from $16 at Stephens

Stephens lowered the firm’s price target on Evolent Health (EVH) to $12 from $16 and keeps an Equal Weight rating on the shares. The firm is negatively revising its Q4 and FY25E EBITDA estimates, but believes visibility is high on revenue, profits, and OpEx for the remainder of the business beyond the Performance Suite business, the analyst tells investors.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue